“We are delighted to be working with Nzomics. They have identified and cloned genes, encoding a range of enzymes for biocatalytic synthesis to be used in the field of chiral pharmaceutical intermediates – successfully adding to Almac’s growing proprietary enzyme collection.”
Dr Tom Moody, New Technology Team Leader, Almac Sciences
“Megazyme have used protein identification services from Nzomics on numerous occasions and
each time received impressive customer support and rapid turnaround enabling new analytical
products to be developed within exacting deadlines. Nzomics have also successfully delivered
specific enzyme activities requested by Megazyme on a royalty basis arrangement.”
Dr Simon Charnock, Senior Scientist, Megazyme International